Alasdair Hubbard

@dralhubb.bsky.social

Assistant Professor - research group works on the evolution of AMR and understanding cryptic mechanisms of resistance. All views my own. T1D

Am I being impatient or is this unreasonable? Submitted a manuscript in July 2025, 2 rounds of review then transferred to another of their journals with reviewers comments (R1 accepted, R2 minor comments). We made the changes and re-submitted ~3 months ago.. heard nothing since. #MicroSky

Ad forthcoming, but I am hiring for a postdoc or staff scientist to advance related investigations of the virus-host conflict. This position is ~80-100% computational, but with opportunities for experimental work if desired. If interested, shoot me an email with your CV! Reposts appreciated! 15/15

🧪🐍 New paper accepted! We screened 14 snake venoms for antimicrobial activity and identified candidate venom proteins with activity against E. coli, including phospholipases and neurotoxins. A cool example of looking for new antimicrobials in unexpected places. doi.org/10.1099/acmi... #MicroSky

Screening the antimicrobial properties of snake venoms: an iterative fractionation approach

Antimicrobial resistance (AMR) increasingly poses a significant global health challenge. New antimicrobials are desperately needed, driving the need to explore novel sources of natural products. Snake...

doi.org

🧪🐍 New paper accepted! We screened 14 snake venoms for antimicrobial activity and identified candidate venom proteins with activity against E. coli, including phospholipases and neurotoxins. A cool example of looking for new antimicrobials in unexpected places. doi.org/10.1099/acmi... #MicroSky

Screening the antimicrobial properties of snake venoms: an iterative fractionation approach

Antimicrobial resistance (AMR) increasingly poses a significant global health challenge. New antimicrobials are desperately needed, driving the need to explore novel sources of natural products. Snake...

doi.org

Awesome to attend the APPG on UTIs today in the Houses of Parliament. Despite the incredibly warm weather (I cant handle heat), its always great as a scientist to listen to the people affected by UTIs and the clinicians that treated them, it really does shape the research we do! #UTISky #MicroSky

An interesting take on the impact of mutation heterogeneity in a population, the impact on growth rates (via birth/death rates), role of tolerance to facilitate resistance development and assessment of resistance. My opinion (not that anyone asked!) is that from a treatment approach mindset..(1/3)

Craig MacLean@craigmaclean.bsky.social · last mo.

New #microsky#AMR Perspective paper with @penamiller.bsky.social rdcu.be/fqBJo ANTIBIOTIC RESISTANCE (IE MIC) AND TOLERANCE ARE NOT BACTERIAL TRAITS! Please read on if you want an explanation for this provocative claim.

This is the key point for the UK as well. Due to the current "efficiencies" at many universities, research is being pushed more and more into the background and academics end up working more hours to write the grants, papers, etc but the Unis take the part of the credit when its successful

Kate Clancy@kateclancy.bsky.social · last mo.

What's baffling about how underfunded services are that help faculty get grants is that we bring money into the univ. They care about that overhead. But not enough, I guess, to fund the grant workers because they know faculty are workaholics & will just work more hours if we have less support.

What's baffling about how underfunded services are that help faculty get grants is that we bring money into the univ. They care about that overhead. But not enough, I guess, to fund the grant workers because they know faculty are workaholics & will just work more hours if we have less support.

Welcome for complicated UTIs w/ resistant bugs but oral carbapenem lower the last barrier protecting this important antibiotic class Convenience for patients must not become convenience for prescribers, otherwise we may pay with increased carbapenem resistance #AMR www.cidrap.umn.edu/antimicrobia...

FDA approves new oral antibiotic for complicated urinary tract infections

Utebzi is the first oral carbapenem antibiotic approved in the US.

cidrap.umn.edu

It was such a good talk @c-cornbill.bsky.social won the best talk prize! @friendlymicrobe.bsky.social 2 in 2 months, what a star! #MicroSky

Alasdair Hubbard@dralhubb.bsky.social · 2mo ago

Wonderful talk by @c-cornbill.bsky.social , PhD student with @friendlymicrobe.bsky.social and I on her work on the effect of media on P. aeruginosa evolution to meropenem at the #MNGPopUp. This work leads beautifully into her work using the ex vivo pig lung model!